{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:03:25Z","timestamp":1780553005702,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychiatr"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40211-018-0259-0","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T14:54:47Z","timestamp":1520434487000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["No evidence of subgroups found in amphetamine consumers in Iran","Keine Belege f\u00fcr Subgruppen bei Amphetaminkonsumenten im Iran"],"prefix":"10.1007","volume":"32","author":[{"given":"Atireza","family":"Bananej","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"V\u00f6lkl-Kernstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Lesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Skala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"259_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2008-2231-21-22","volume":"21","author":"AZ Mehrjerdi","year":"2013","unstructured":"Mehrjerdi AZ. Crystal in Iran: methamphetamine or heroin Kerack. Daru. 2013;21:22.","journal-title":"Daru"},{"key":"259_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ajp.2015.06.002","volume":"16","author":"Z Alam-mehrjerdi","year":"2015","unstructured":"Alam-mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a\u00a0unique model of health in themost populated Persian Gulf country. Asian J Psychiatr. 2015;16:78\u201383.","journal-title":"Asian J Psychiatr"},{"key":"259_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajp.2015.05.036","volume":"16","author":"Z Alam-mehrjerdi","year":"2015","unstructured":"Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatmentin Iran: a\u00a0review from the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:17\u201325.","journal-title":"Asian J Psychiatr"},{"key":"259_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00952990902968585","volume":"35","author":"WS Cheng","year":"2009","unstructured":"Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Diff erences in sexual risk behaviors among male and female HIV-seronegative heterosexual methamphetamine users. Am J Drug Alcohol Abuse. 2009;35:295\u2013300.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"259_CR5","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","volume":"68","author":"GN Colfax","year":"2011","unstructured":"Colfax GN, Santos GM, Das M, Santos DM, Matheson T, Gasper J, Shoptaw S, Vittinghoff E. Mirtazapine to reduce methamphetamine use: a\u00a0randomized controlled trial. Arch Gen Psychiatry. 2011;68:1168\u201375.","journal-title":"Arch Gen Psychiatry"},{"key":"259_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugalcdep.2013.12.025","volume":"137","author":"L Degenhardt","year":"2014","unstructured":"Degenhardt L, Baxter AJ, Lee YY, Hall W, Grant ES, Johns N, et\u00a0al. The globalepidemiology and burden of psychostimulant dependence: findings from the global burden of disease study 2010. Drug Alcohol Depend. 2014;137:36\u201344.","journal-title":"Drug Alcohol Depend"},{"issue":"9904","key":"259_CR7","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","volume":"382","author":"L Degenhardt","year":"2013","unstructured":"Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, Freedman G, Burstein R, Johns N, Engell RE, Flaxman A, Murray CJ, Vos T. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564\u201374.","journal-title":"Lancet"},{"key":"259_CR8","doi-asserted-by":"crossref","first-page":"305e17","DOI":"10.31887\/DCNS.2009.11.3\/egmayfrank","volume":"11","author":"E Gouzoulis-Mayfrank","year":"2009","unstructured":"Gouzoulis-Mayfrank E, Daumann J. Neurotoxicity of drugs of abused\u2014the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci. 2009;11:305e17.","journal-title":"Dialogues Clin Neurosci"},{"key":"259_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1359105308100206","volume":"14","author":"PN Halkitis","year":"2009","unstructured":"Halkitis PN, Solomon TM, Moeller RW, et al. Methamphetamine use among gay, bisexual and non-identifi ed men-who-have-sex with-men: an analysis of daily patterns. J\u00a0Health Psychol. 2009;14:222\u201331.","journal-title":"J Health Psychol"},{"key":"259_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/10550880802122554","volume":"27","author":"YI Hser","year":"2008","unstructured":"Hser YI, Huang D, Brecht ML, Li L, Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J\u00a0Addict Dis. 2008;27:13\u201321.","journal-title":"J Addict Dis"},{"key":"259_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/09595230801914784","volume":"27","author":"A Inglez-Dias","year":"2008","unstructured":"Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008;27:286\u201391.","journal-title":"Drug Alcohol Rev"},{"key":"259_CR12","volume-title":"How to address methamphetamine involvement in OST settings","author":"S Jafari","year":"2011","unstructured":"Jafari S, Noroozi A, Razzaghie EM, Shafiee SA, Naghshvarian M. How to address methamphetamine involvement in OST settings. Harm Reduction\u2019s 22ND International Conference; Beirut. : ; 2011. http:\/\/www.ihra.net . Accessed 23 May 2017."},{"key":"259_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","volume":"69","author":"L Karila","year":"2010","unstructured":"Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL. Pharmacological approaches to methamphetamine dependence: a\u00a0focused review. Br J Clin Pharmacol. 2010;69:578\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"259_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5812\/ijhrba.5336","volume":"1","author":"K Lashkaripour","year":"2012","unstructured":"Lashkaripour K, Torbati E. Methamphetamine dependence. Int J High Risk Behav Addict. 2012;1:7\u20138.","journal-title":"Int J High Risk Behav Addict"},{"key":"259_CR15","first-page":"380","volume":"24","author":"OM Lesch","year":"1989","unstructured":"Lesch OM, Bonte W, Kefer J, Mader R, Musalek M, Nimmerrichter A, Sprung R, Walter H. A new typology in chronic alcoholism and its biological markers. Alcohol Alcohol. 1989;24:380.","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"259_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000077945","volume":"50","author":"OM Lesch","year":"2004","unstructured":"Lesch OM, Dvorak A, Hertling I, Klingler A, Kunze M, Ramskogler K, Saletu-Zyhlarz G, Schoberberger R, Walter H. The Austrian multicentre study on smoking: subgroups of nicotine dependence and their craving. Neuropsychobiology. 2004;50(1):78\u201388.","journal-title":"Neuropsychobiology"},{"key":"259_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/oxfordjournals.alcalc.a008221","volume":"31","author":"OM Lesch","year":"1996","unstructured":"Lesch OM, Walter H. Subtypes of alcoholism and their role in therapy. Alcohol Alcohol. 1996;31:63\u20137.","journal-title":"Alcohol Alcohol"},{"key":"259_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.drugalcdep.2012.10.009","volume":"130","author":"JZ Ma","year":"2013","unstructured":"Ma JZ, Johnson BA, Yu E, Weiss D, McSherry F, Saadvandi J, Iturriaga E, Ait-Daoud N, Rawson RA, Hrymoc M, Campbell J, Gorodetzky C, et al. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis. Drug Alcohol Depend. 2013;130:45\u201351.","journal-title":"Drug Alcohol Depend"},{"key":"259_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1360-0443.2002.00143.x","volume":"97","author":"T Matsumoto","year":"2002","unstructured":"Matsumoto T, Kamijo A, Miyakawa T, et\u00a0al. Methamphetamine in Japan: the consequences of methamphetamine abuse as a\u00a0function of route of administration. Addiction. 2002;97:809\u201317.","journal-title":"Addiction"},{"key":"259_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.01.018","volume":"161","author":"R McKetin","year":"2016","unstructured":"McKetin R, Dawe S, Burns RA, Hides L, Kavanagh DJ, Teesson M, Mc DYoung R, Voce A, Saunders JB. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend. 2016;161:104\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"259_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/13543784.2017.1313229","volume":"26","author":"KC Morley","year":"2017","unstructured":"Morley KC, Cornish JL, Faingold A, Wood K, Haber PS. Pharmacotherapeutic agents in the treatment of methamphetamine dependence. Expert Opin Investig Drugs. 2017;26(5):563\u201378.","journal-title":"Expert Opin Investig Drugs"},{"key":"259_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0091-3057(97)00251-7","volume":"58","author":"F Musshoff","year":"1997","unstructured":"Musshoff F, Daldrup T, Bonte W, Leitner A, Lesch OM. Salsolinol and norsalsolinol in human urine samples. Pharmacol Biochem Behav. 1997;58:545\u201350.","journal-title":"Pharmacol Biochem Behav"},{"key":"259_CR23","volume-title":"Medications development research for treatment of amphetamine and methamphetamine addiction","author":"National Institute on Drug Abuse (NIDA)","year":"2005","unstructured":"National Institute on Drug Abuse (NIDA). Medications development research for treatment of amphetamine and methamphetamine addiction. Bethesda: U.S. Department of Health and Human Services, National Institutes of Health; 2005."},{"key":"259_CR24","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","volume":"31","author":"TF Newton","year":"2006","unstructured":"Newton TF, Roache JD, De La Garza R 2nd, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology. 2006;31:1537\u201344.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"259_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.26719\/2017.23.3.245","volume":"23","author":"B Shadloo","year":"2017","unstructured":"Shadloo B, Amin-Esmaeili M, Haft-Baradaran M, Noroozi A, Ghorban-Jahromi R, Rahimi-Movaghar A. Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004\u20132015: a\u00a0review. East Mediterr Health\u00a0J. 2017;23(3):245\u201356.","journal-title":"East Mediterr Health J"},{"key":"259_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsat.2006.06.012","volume":"32","author":"J Shearer","year":"2007","unstructured":"Shearer J. Psychosocial approaches to psychostimulant dependence: a\u00a0systematic review. J\u00a0Subst Abuse Treat. 2007;32:41\u201352.","journal-title":"J Subst Abuse Treat"},{"key":"259_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jadohealth.2008.06.021","volume":"44","author":"SG Sherman","year":"2009","unstructured":"Sherman SG, Sutcliff CG, German D, Sirirojn B, Aramrattana A, Celentano DD. Patterns of risky behaviors associated with methamphetamine use among young Thai adults: a\u00a0latent class analysis. J\u00a0Adolesc Health. 2009;44:169\u201375.","journal-title":"J Adolesc Health"},{"key":"259_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/alcalc\/35.4.394","volume":"35","author":"W Sperling","year":"2000","unstructured":"Sperling W, Frank H, Martus P, Mader R, Barocka A, Walter H, Lesch OM. The concept of abnormal hemispheric organization in addiction research. Alcohol Alcohol. 2000;35:394\u20139.","journal-title":"Alcohol Alcohol"},{"key":"259_CR29","unstructured":"UNODOC 2008 World Drug report. https:\/\/www.unodc.org\/documents\/wdr\/WDR_2008\/WDR_2008_eng_web.pdf . Accessed 24.2.2018."},{"key":"259_CR30","doi-asserted-by":"crossref","DOI":"10.18356\/94bbf1f4-en","volume-title":"World drug report 2012","author":"UN Office on Drugs and Crime","year":"2012","unstructured":"UN Office on Drugs and Crime. World drug report 2012. New York: United Nations; 2012."},{"issue":"Suppl 1","key":"259_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1360-0443.2007.01772.x","volume":"102","author":"FJ Vocci","year":"2007","unstructured":"Vocci FJ, Appel NM. Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction. 2007;102(Suppl 1):96\u2013106.","journal-title":"Addiction."},{"key":"259_CR32","doi-asserted-by":"publisher","first-page":"181e90","DOI":"10.1080\/10550490490436055","volume":"13","author":"JE Zweben","year":"2004","unstructured":"Zweben JE, Cohen JB, Christian D, et\u00a0al. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13:181e90.","journal-title":"Am J Addict"}],"container-title":["neuropsychiatrie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40211-018-0259-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-018-0259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-018-0259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T13:57:01Z","timestamp":1660571821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40211-018-0259-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["259"],"URL":"https:\/\/doi.org\/10.1007\/s40211-018-0259-0","relation":{},"ISSN":["0948-6259","2194-1327"],"issn-type":[{"value":"0948-6259","type":"print"},{"value":"2194-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"30 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Bananej, S.\u00a0V\u00f6lkl-Kernstock, O.\u00a0Lesch, H.\u00a0Walter, and K.\u00a0Skala declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}